These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31650973)

  • 1. Embolization of variant hepatic arteries in patients undergoing percutaneous hepatic perfusion for unresectable liver metastases from ocular melanoma.
    Meijer TS; Geus-Oei LF; Martini CH; Tijl FGJ; Sitsen ME; Erkel ARV; Meer RWV; Kapiteijn E; Vahrmeijer AL; Burgmans MC
    Diagn Interv Radiol; 2019 Nov; 25(6):451-458. PubMed ID: 31650973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coil Embolization of Variant Hepatic Arteries During Percutaneous Arterial Port Catheter Placement for Intraarterial Chemotherapy: Analysis of Intrahepatic Perfusion Redistribution and Treatment Efficacy.
    Kobe A; Deschamps F; Meyblum L; Varin E; Delpla A; Hakime A; Teriitehau C; Roux C; Boileve A; Gelli M; de Baère T; Tselikas L
    Cardiovasc Intervent Radiol; 2023 Jan; 46(1):69-79. PubMed ID: 36319713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems' Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial.
    Meijer TS; Burgmans MC; Fiocco M; de Geus-Oei LF; Kapiteijn E; de Leede EM; Martini CH; van der Meer RW; Tijl FGJ; Vahrmeijer AL
    Cardiovasc Intervent Radiol; 2019 Jun; 42(6):841-852. PubMed ID: 30767147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases.
    Hughes MS; Zager J; Faries M; Alexander HR; Royal RE; Wood B; Choi J; McCluskey K; Whitman E; Agarwala S; Siskin G; Nutting C; Toomey MA; Webb C; Beresnev T; Pingpank JF
    Ann Surg Oncol; 2016 Apr; 23(4):1309-19. PubMed ID: 26597368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic Flow Redistribution is Feasible in Patients with Hepatic Malignancies Undergoing Same-Day Work-Up Angiography and Yttrium-90 Microsphere Radioembolization.
    Ezponda A; Rodríguez-Fraile M; Morales M; Vivas I; De La Torre M; Sangro B; Bilbao JI
    Cardiovasc Intervent Radiol; 2020 Jul; 43(7):987-995. PubMed ID: 31848672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioembolization of hepatic tumors: flow redistribution after the occlusion of intrahepatic arteries.
    Lauenstein TC; Heusner TA; Hamami M; Ertle J; Schlaak JF; Gerken G; Bockisch A; Antoch G
    Rofo; 2011 Nov; 183(11):1058-64. PubMed ID: 21959887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of intrahepatic perfusion on fusion imaging using a combined CT/SPECT system: influence of anatomic variations on hemodynamic modification before installation of implantable port systems for hepatic arterial infusion chemotherapy.
    Ikeda O; Tamura Y; Nakasone Y; Shiraishi S; Kawanaka K; Tomiguchi S; Takamori H; Chikamoto A; Kanemitsu K; Yamashita Y
    Cardiovasc Intervent Radiol; 2007; 30(3):383-91. PubMed ID: 17225972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver.
    Alexander HR; Libutti SK; Bartlett DL; Puhlmann M; Fraker DL; Bachenheimer LC
    Clin Cancer Res; 2000 Aug; 6(8):3062-70. PubMed ID: 10955785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease.
    Karydis I; Gangi A; Wheater MJ; Choi J; Wilson I; Thomas K; Pearce N; Takhar A; Gupta S; Hardman D; Sileno S; Stedman B; Zager JS; Ottensmeier C
    J Surg Oncol; 2018 May; 117(6):1170-1178. PubMed ID: 29284076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy assessment of flow redistribution by occlusion of intrahepatic vessels prior to radioembolization in the treatment of liver tumors.
    Bilbao JI; Garrastachu P; Herráiz MJ; Rodríguez M; Iñarrairaegui M; Rodríguez J; Hernández C; de la Cuesta AM; Arbizu J; Sangro B
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):523-31. PubMed ID: 19841973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Parameters in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan for Unresectable Liver Metastases from Uveal Melanoma: A Retrospective Pooled Analysis.
    Tong TML; Samim M; Kapiteijn E; Meijer TS; Speetjens FM; Brüning R; Schroeder TH; El-Sanosy S; Maschke H; Wacker FK; Vogel A; Dewald CLA; Goeman JJ; Burgmans MC
    Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1304-1313. PubMed ID: 35922562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over 12 Years Single Institutional Experience Performing Percutaneous Hepatic Perfusion for Unresectable Liver Metastases.
    Carr MJ; Sun J; Cohen JB; Liu J; Serdiuk AA; Stewart SR; Doobay N; Duclos A; Seal DA; Choi J; Zager JS
    Cancer Control; 2020; 27(1):1073274820983019. PubMed ID: 33372814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemosaturation with percutaneous hepatic perfusion is effective in patients with ocular melanoma and cholangiocarcinoma.
    Schönfeld L; Hinrichs JB; Marquardt S; Voigtländer T; Dewald C; Koppert W; Manns MP; Wacker F; Vogel A; Kirstein MM
    J Cancer Res Clin Oncol; 2020 Nov; 146(11):3003-3012. PubMed ID: 32564137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic artery infusion of melphalan in patients with liver metastases from ocular melanoma.
    Boone BA; Perkins S; Bandi R; Santos E; McCluskey K; Bartlett DL; Pingpank JF
    J Surg Oncol; 2018 Apr; 117(5):940-946. PubMed ID: 29878390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver.
    Alexander HR; Libutti SK; Pingpank JF; Steinberg SM; Bartlett DL; Helsabeck C; Beresneva T
    Clin Cancer Res; 2003 Dec; 9(17):6343-9. PubMed ID: 14695133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemosaturation with percutaneous hepatic perfusion for unresectable isolated hepatic metastases from sarcoma.
    Deneve JL; Choi J; Gonzalez RJ; Conley AP; Stewart S; Han D; Werner P; Chaudhry TA; Zager JS
    Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1480-7. PubMed ID: 22699779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases.
    Tong TML; Fiocco M; van Duijn-de Vreugd JJ; Lutjeboer J; Speetjens FM; Tijl FGJ; Sitsen ME; Zoethout RWM; Martini CH; Vahrmeijer AL; van der Meer RW; van Rijswijk CSP; van Erkel AR; Kapiteijn E; Burgmans MC
    Cardiovasc Intervent Radiol; 2024 Jun; 47(6):741-750. PubMed ID: 38587534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
    Meijer TS; Burgmans MC; de Leede EM; de Geus-Oei LF; Boekestijn B; Handgraaf HJM; Hilling DE; Lutjeboer J; Vuijk J; Martini CH; van Erkel AR; van der Meer RW; Tijl FGJ; Speetjens FM; Kapiteijn E; Vahrmeijer AL
    Ann Surg Oncol; 2021 Feb; 28(2):1130-1141. PubMed ID: 32761328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan.
    de Leede EM; Burgmans MC; Meijer TS; Martini CH; Tijl FGJ; Vuyk J; van Erkel AR; van der Velde CJH; Kapiteijn E; Vahrmeijer AL
    Cardiovasc Intervent Radiol; 2017 Aug; 40(8):1196-1205. PubMed ID: 28451811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemosaturation with percutaneous hepatic perfusion of melphalan for liver-dominant metastatic uveal melanoma: a single center experience.
    Artzner C; Mossakowski O; Hefferman G; Grosse U; Hoffmann R; Forschner A; Eigentler T; Syha R; Grözinger G
    Cancer Imaging; 2019 May; 19(1):31. PubMed ID: 31146793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.